Rice Hall James & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RB Global
RBA
|
+$12.2M |
| 2 |
Pacira BioSciences
PCRX
|
+$12.2M |
| 3 |
Doximity
DOCS
|
+$8.19M |
| 4 |
Establishment Labs
ESTA
|
+$6.27M |
| 5 |
Columbia Banking Systems
COLB
|
+$5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IAA
IAA, Inc. Common Stock
IAA
|
+$17.7M |
| 2 |
Medifast
MED
|
+$17.2M |
| 3 |
ALBO
Albireo Pharma Inc
ALBO
|
+$11.1M |
| 4 |
iShares Russell 2000 Growth ETF
IWO
|
+$6.11M |
| 5 |
WNS
WNS Holdings
WNS
|
+$5.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.26% |
| 2 | Technology | 26.93% |
| 3 | Industrials | 17.12% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 6.84% |
Similar funds
Rice Hall James & Associates's Q1 2023 Portfolio in Review
As of Q1 2023, Rice Hall James & Associates held 275 positions worth $1.76B, up 0.96% from $1.74B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rice Hall James & Associates withdrew a net $84.9M in Q1 2023, closing 13 positions and reducing 181 holdings. Its most notable exit was IAA, Inc. Common Stock, an estimated $17.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.
Against the trend, Rice Hall James & Associates opened a new position in RB Global worth $11.7M.
- Rice Hall James & Associates's largest Q1 2023 buy was RB Global: 207,333 shares worth $11.7M.
- Rice Hall James & Associates added most to Pacira BioSciences in Q1 2023, an estimated $12.2M increase.
- Rice Hall James & Associates's biggest Q1 2023 reduction was Medifast, cutting an estimated $17.2M.
- Rice Hall James & Associates fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $17.7M.
- Rice Hall James & Associates's ten largest holdings make up 24% of its $1.76B portfolio in Q1 2023.
- Rice Hall James & Associates opened 15 new positions and closed 13 in Q1 2023.
- Rice Hall James & Associates's portfolio value rose 0.96% quarter-over-quarter to $1.76B.
Based on Rice Hall James & Associates's 13F filing for Q1 2023, filed 12 May 2023.